SLC7A14, a new pathogenic gene of RP, was discovered for the first time and won the award with the first artificial corneal lamellar transplantation in the world.
With the theme of "gathering global strength to create a future of ophthalmology", the Fifth Global Chinese Ophthalmology Conference and the 21st National Ophthalmology Conference of the Chinese Medical Association were held in Suzhou from September 7 to 11. The award is dedicated to young and middle-aged ophthalmic clinical researchers who have made outstanding contributions in the field of clinical and scientific innovation. The award ceremony of "He Eye Innovation Award of the Ophthalmology Branch of the Chinese Medical Association" was held on September 8 during the conference
The third "He Eye Innovation Award" award scene.
The Innovation Award welcomes the new winners and a great number of talents on the way to Innovation.
In the evening of September 8, 2016, the third He Eye Innovation Award ceremony was held in Suzhou. After strict selection, Jin Zibing, director of genetic ophthalmology and doctoral supervisor of the affiliated Eye Optometry Hospital of Wenzhou Medical University, and Zhang Mingchang, director of ophthalmology and doctoral supervisor of Wuhan Union Hospital, became the winners of the new "He Eye Innovation Award." They won a bonus of 100,000 yuan.
Professor Zhang Mingchang has carried out the first artificial biological corneal lamellar transplantation. This product has been approved and listed by the state and has been popularized and applied in the whole country. Zhang Mingchang has promoted the listing of independent intellectual property rights in China, which has played a historic role in the treatment of corneal blindness in China.
Professor Jin Zibing has done a lot of exploratory research on the basic and clinical problems of hereditary ophthalmopathy. He found SLC7A14 for the first time, a new pathogenic gene of RP. He also has a number of national invention patents in stem cell transformation research.
Prof. Qu Jia (first from left) and Prof. Yang Peizeng (first from right) presented awards to two scientists, Jin Zibing (second from left) and Zhang Mingchang (third from left).
When giving this award speech, Prof. Zhang Mingchang mentioned three words: HESH, ophthalmology and innovation. He said that while HESH are developing and growing, it has also given great encouragement to ophthalmology innovation. Without HESH, he could not have won the award. Ophthalmology has seen great progress in recent years and He is very proud to be an ophthalmologist. Innovation is the soul of the nation and the key factor of progress and he will continue to work hard to this end.
Prof. Jin Zibing believes that winning the "He Eye Innovation Award" is not only an incentive to him personally, but also to a large number of young and middle-aged researchers who do research from a clinical point of view and promote clinical science from a technical point of view.
He Wei, founder of He Eye Innovation Award: realizing the dream of revitalization of the Chinese nation through innovation.
As the founder of the "He Eye Innovation Award," Dr. He Wei president of He University and He Eye Specialist Hospital, said of the original intention of setting up the award: I am a poor student, and when the 1 million prize was handed out to me, I don't think this award should be given to me. Although the distance between Chinese ophthalmology and international ophthalmology is already narrowing in many ways, and even exceeds the international level in some aspects, there are a few things that we still need to improve. So I donated the money.
Dr. He Wei is giving the speech
Dr. He Wei further pointed out that innovation first requires talent innovation. The training of our basic education, resident system and subspecialty system still needs to be improved, because the high-end equipment, drugs and consumables we use now are still made abroad. Only talent innovation can improve our ability of independent innovation.
On the other hand, we need the innovation of values, because with the development of economy and the change of society, our values have been greatly impacted. How to stick to them and make the dream of rejuvenation of the Chinese nation come true requires the innovation of values.
Dr. He hopes to promote the following aspects: Mission, Vision and Action through the establishment of the He Eye Innovation Award. He pointed out that there are currently 20 million people with visual impairment in China, and it is the mission of all ophthalmologists to help them recover. In the internet age, how China and the world will change requires an open and innovative vision, all of which require practical action.
In order to support and encourage the innovation of young and middle-aged ophthalmologists, train outstanding innovative ophthalmologists, promote the independent innovation of ophthalmology and the development of prevention and treatment of blindness, He Wei, chairman of the International Blindness Prevention Association West Asia Pacific, member of the standing Committee of the Ophthalmology Branch of the Chinese Medical Association, member of the National Committee of the Chinese People's Political Consultative Conference, and president of He Eye Hospital, donated a prize of 1 million yuan to the Liaoning Light of Care Blindness Prevention Foundation. The "He Eye Innovation Award" has been set up in the ophthalmology branch of the Chinese Medical Association to reward young and middle-aged innovative talents in ophthalmology clinical, scientific research and prevention of blindness in the form of an annual prize of 100,000 yuan.
The He Eye Innovation Award was officially established at the 18th National Ophthalmology Congress on September 13, 2013, and two award ceremonies were successfully held in September 2014 and August 2015. Seven ophthalmologists were awarded the award.
In 2014, the winners of the first "He Eye Innovation Award":
Theoretical Innovation Award-Wang Ningli, Beijing Tongren Hospital affiliated to Capital Medical University.
Technology Innovation Award-Li Xiaoxin, People's Hospital of Peking University.
New Drug and Equipment Innovation Award-Qu Jia of Wenzhou Medical University and Xie Lixin of Shandong Institute of Ophthalmology.
Youth Innovation Award-Zhou Xiangtian of Wenzhou Medical University and Zhao Mingwei of People's Hospital of Peking University.
In 2015, the second He Eye Innovation Award was awarded to Zhao Chen, the First Affiliated Hospital of Nanjing Medical University.